Skip to content
中文产业新闻精选评分80Chinese source

FDA 批准 Brepocitinib 上市，用于治疗皮肌炎

全球首个 TYK2/JAK1 抑制剂获批上市

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.